Siemens Healthineers AG (0PMJ)
London Exchange · UK · prices in EUR · close of 20 Oct 2026
Key indicators
| Last close | EUR 41.11 |
|---|---|
| 52-week range | 32.82 – 48.52 |
| Return, 1 month / 3 months | +8.4% / +20.5% |
| Return, 1 year / 3 years | −11.8% / −8.9% |
| Trend | Uptrend |
| RSI (14) | 67 |
| Volatility (1 year) | 24.6% |
| Worst drawdown (1 year) | -31.2% |
| Average daily value traded | 12.19M EUR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Siemens Healthineers is a medical technology company based in Germany that supplies hospitals, clinics and laboratories around the world. It makes imaging systems such as magnetic resonance and computed tomography scanners, ultrasound machines and X-ray equipment, along with laboratory diagnostics and cancer treatment devices. The company also offers services and software that help healthcare providers run their equipment and manage patient care, serving customers across many countries.
The shares are listed on the London Exchange in UK under the code 0PMJ, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Siemens Healthineers AG (0PMJ) trades on the London Exchange in UK. It last closed at EUR 41.11 on 20 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 1,169 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.8% and over the last three months it rose 20.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 8.1% | ||
| From 52-week high | -15.1% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 20.5% | ||
| 6-month return | 9.5% | ||
| 12-month return, skipping the last month | -18.7% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 24.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.2% | ||
| Liquidity | 75 · Strong | Trades actively. | |
| Average daily value traded | 12.19M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.1% |
|---|---|
| 1 month | +8.4% |
| 3 months | +20.5% |
| 6 months | +9.5% |
| 1 year | −11.8% |
| 3 years | −8.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 38.99 / 38.04 |
|---|---|
| Golden / death cross (60 days) | Golden, 16 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.77 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Feb 2026 | EUR 1.0000 |
| 19 Feb 2025 | EUR 0.9500 |
| 19 Apr 2024 | EUR 0.9500 |
| 16 Feb 2023 | EUR 0.9500 |
| 14 Feb 2022 | EUR 0.8500 |
| 15 Feb 2021 | EUR 0.8000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.